Detalhe da pesquisa
1.
Current advances in targeted therapies for metastatic gastric cancer: improving patient care.
Future Oncol
; 12(6): 839-54, 2016 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26838766
2.
Definitive chemoradiotherapy for squamous head and neck cancer: cisplatin versus carboplatin? A meta-analysis.
Future Oncol
; 12(23): 2755-2764, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27549331
3.
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis.
J Gastrointest Oncol
; 15(1): 33-51, 2024 Feb 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38482212
4.
Challenges and opportunities in building a health economic framework for personalized medicine in oncology.
Per Med
; 20(5): 453-460, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37602420
5.
Discrepancies Between the Cost of Advanced Lung Cancer Treatment and How Much Is Reimbursed by the Brazilian Public Healthcare System.
Value Health Reg Issues
; 33: 1-6, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162194
6.
Predictive genetic biomarkers in immune checkpoint inhibitors for non-small-cell lung cancer.
Immunotherapy
; 14(4): 249-257, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35076285
7.
Cost-effectiveness analysis of Ado-trastuzumab emtansine for the treatment of residual invasive HER2-positive breast cancer.
Einstein (Sao Paulo)
; 20: eGS6655, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544899
8.
Laboratory variables as predictors of progression in gastroenteropancreatic neuroendocrine tumors in different lines of antineoplastic treatments.
Einstein (Sao Paulo)
; 20: eAO6985, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674592
9.
Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials.
Cancers (Basel)
; 13(11)2021 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34073475
10.
Palliative Prognostic Index accuracy of survival prediction in an inpatient palliative care service at a Brazilian tertiary hospital.
Ecancermedicalscience
; 15: 1228, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158832
11.
Treating operable patients with gastric cancer: Macdonald's protocol versus adjuvant chemotherapy.
Future Oncol
; 11(16): 2247-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260801
12.
Cost-effectiveness and affordability of anticancer treatment in Brazil.
Ecancermedicalscience
; 14: ed96, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32153659
13.
Cost-effectiveness analysis of abiraterone, docetaxel or placebo plus androgen deprivation therapy for hormone-sensitive advanced prostate cancer.
Einstein (Sao Paulo)
; 17(2): eGS4414, 2019 Mar 07.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-30843996
14.
A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitors.
Drugs Context
; 7: 212555, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30416529
15.
Cost effectiveness of chemohormonal therapy in patients with metastatic hormone-sensitive and non-metastatic high-risk prostate cancer.
Einstein (Sao Paulo)
; 15(3): 349-354, 2017.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-29091159
16.
Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets.
ESMO Open
; 2(3): e000200, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29209522
17.
Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma-Renewed Enthusiasm and a Lingering Challenge.
JAMA Oncol
; 7(11): 1613-1614, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519775
18.
Disparities in cancer epidemiology and care delivery among Brazilian indigenous populations.
Einstein (Sao Paulo)
; 14(3): 330-337, 2016.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-27759820
19.
MetaLanc9 as a novel biomarker for non-small cell lung cancer: promising treatments via a PGK1-activated AKT/mTOR pathway.
J Thorac Dis
; 10(Suppl 17): S2076-S2078, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30023123
20.
MMR deficiency may lead to a high immunogenicity and then an improvement in anti-PD-1 efficacy for metastatic colorectal cancer.
Immunotherapy
; 7(11): 1133-4, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26568256